NO820686L - Fremgangsmaate ved fremstilling av nye aroylimidazoloner - Google Patents

Fremgangsmaate ved fremstilling av nye aroylimidazoloner

Info

Publication number
NO820686L
NO820686L NO820686A NO820686A NO820686L NO 820686 L NO820686 L NO 820686L NO 820686 A NO820686 A NO 820686A NO 820686 A NO820686 A NO 820686A NO 820686 L NO820686 L NO 820686L
Authority
NO
Norway
Prior art keywords
aroylimidazolons
procedure
preparation
new
aroylimidazole
Prior art date
Application number
NO820686A
Other languages
English (en)
Other versions
NO157175C (no
NO157175B (no
Inventor
Richard C Dage
Frank P Palopoli
Richard A Schnettler
J Martin Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO820686L publication Critical patent/NO820686L/no
Publication of NO157175B publication Critical patent/NO157175B/no
Publication of NO157175C publication Critical patent/NO157175C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
NO820686A 1981-03-05 1982-03-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner. NO157175C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use

Publications (3)

Publication Number Publication Date
NO820686L true NO820686L (no) 1982-09-06
NO157175B NO157175B (no) 1987-10-26
NO157175C NO157175C (no) 1988-02-03

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820686A NO157175C (no) 1981-03-05 1982-03-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner.

Country Status (18)

Country Link
US (1) US4405628A (no)
EP (1) EP0059948B1 (no)
KR (1) KR890000765B1 (no)
AT (1) ATE16489T1 (no)
AU (1) AU557590B2 (no)
CA (1) CA1190550A (no)
DE (1) DE3267352D1 (no)
DK (1) DK168627B1 (no)
ES (2) ES8305352A1 (no)
GB (1) GB2096600B (no)
GR (1) GR76518B (no)
HK (1) HK61686A (no)
IE (1) IE52387B1 (no)
IL (1) IL65137A (no)
MY (1) MY8600700A (no)
NO (1) NO157175C (no)
NZ (1) NZ199885A (no)
PH (1) PH18345A (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
ZA855592B (en) * 1984-07-30 1986-03-26 Merrell Dow Pharma The preparation of 1,3-dihydro-4-pyridoyl-2h-imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
WO1992000282A1 (en) * 1990-06-29 1992-01-09 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP6251038B2 (ja) 2011-03-01 2017-12-20 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃアゴニストの調製方法
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
DK95482A (da) 1982-09-06
PH18345A (en) 1985-06-05
NO157175C (no) 1988-02-03
ES510087A0 (es) 1983-04-16
ATE16489T1 (de) 1985-11-15
US4405628A (en) 1983-09-20
HK61686A (en) 1986-08-29
ES519254A0 (es) 1984-03-01
NO157175B (no) 1987-10-26
CA1190550A (en) 1985-07-16
NZ199885A (en) 1985-04-30
DE3267352D1 (en) 1985-12-19
IL65137A (en) 1987-02-27
ES8402827A1 (es) 1984-03-01
KR890000765B1 (ko) 1989-04-05
AU557590B2 (en) 1986-12-24
MY8600700A (en) 1986-12-31
GB2096600B (en) 1985-06-05
IL65137A0 (en) 1982-05-31
EP0059948A1 (en) 1982-09-15
DK168627B1 (da) 1994-05-09
IE52387B1 (en) 1987-10-14
GR76518B (no) 1984-08-10
ES8305352A1 (es) 1983-04-16
IE820491L (en) 1982-09-05
GB2096600A (en) 1982-10-20
AU8103782A (en) 1982-09-09
KR830009046A (ko) 1983-12-17
EP0059948B1 (en) 1985-11-13

Similar Documents

Publication Publication Date Title
NO820686L (no) Fremgangsmaate ved fremstilling av nye aroylimidazoloner
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
DK103384D0 (da) Quinoloncarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
ES507810A0 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
NO166863C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-substituert-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer ut fra deres tilsvarende nitriler.
IT1193879B (it) Procedimento per il trattamento dello scompenso cardiaco congestivo
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
JPS5536484A (en) Novel 1*44dihydropyridazinee33carboxylic acid derivative
FI803305A7 (fi) Menetelmä uusien sulfonihapposykloalkyyliamidien valmistamiseksi ja niiden käyttö mikromikrobeja tuhoavina aineina.
ES2044853T3 (es) Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
IT8324141A0 (it) Preparato per la cura delle ustioni.
NO156651C (no) Analogifremgangsmaate for fremstilling av forbindelser egnet for behandling eller profylakse av hjertesykdommer.
IT7830959A0 (it) Metodo per la cura della psoriasi.
NO822586L (no) Fremgangsmaate for behandling eller profylakse av hjertesykdommer
IT8009431A0 (it) Procedimento di sterilizzazione impiegante un coadiuvante dell'azione del calore